GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Tandem Capital Management Corp ADV

Tandem Capital Management Corp ADV lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 28,038 shares of the company’s stock after selling 314 shares during the quarter. GE HealthCare Technologies makes up 1.3% of Tandem Capital Management Corp ADV’s investment portfolio, making the stock its 24th largest position. Tandem Capital Management Corp ADV’s holdings in GE HealthCare Technologies were worth $2,168,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Chicago Capital LLC increased its position in GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after purchasing an additional 163 shares in the last quarter. Chilton Capital Management LLC lifted its position in GE HealthCare Technologies by 15.4% during the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after acquiring an additional 164 shares in the last quarter. Procyon Advisors LLC lifted its position in GE HealthCare Technologies by 5.2% during the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after acquiring an additional 175 shares in the last quarter. Meeder Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 5.4% in the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after purchasing an additional 185 shares in the last quarter. Finally, Forum Financial Management LP raised its position in shares of GE HealthCare Technologies by 3.9% in the 3rd quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock valued at $339,000 after purchasing an additional 186 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Mizuho boosted their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Citigroup upped their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. HSBC started coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price objective for the company from $66.00 to $88.00 in a report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Price Performance

GEHC stock traded down $0.77 during trading on Thursday, hitting $85.95. The company had a trading volume of 1,362,869 shares, compared to its average volume of 3,316,483. The company has a fifty day moving average price of $88.91 and a two-hundred day moving average price of $78.32. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The company has a market cap of $39.22 billion, a P/E ratio of 28.46, a P/E/G ratio of 3.00 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.3% compared to the same quarter last year. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.